Immunosuppressive Agents

Displaying 1 - 10 of 10CSV
Raghu, V. K., Rothenberger, S. D., Squires, J. E., Eisenberg, E., Peters, A. L., Halma, J., Antala, S., Batsis, I. D., Zhang, K., Feldman, A. G., Leung, D. H., Lobritto, S. J., Bucuvalas, J., Horslen, S. P., Mazariegos, G. V., & Perito, E. R. (2025). Association Between Early Immunosuppression Center Variability and One‐Year Outcomes After Pediatric Liver Transplant. Pediatric Transplantation, 29(1). Portico. https://doi.org/10.1111/petr.70018
Publication Date
Dall’Era, M., Kalunian, K., Solomons, N., Truman, M., Hodge, L. S., Yap, E., & Askanase, A. D. (2024). Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS. Lupus Science & Medicine, 11(2), e001319. https://doi.org/10.1136/lupus-2024-001319
Publication Date
Huang, X., Salerno, D., Kovac, D., Scheffert, J., Hedvat, J., Carver, B., Choe, J., Shertel, T., Yuzefpolskaya, M., Colombo, P. C., & Jennings, D. L. (2024). Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation. Clinical Transplantation, 38(8). Portico. https://doi.org/10.1111/ctr.15420
Publication Date
Patwardhan, S., Hong, J., & Weiner, J. (2024). Update on Maintenance Immunosuppression in Intestinal Transplantation. Gastroenterology Clinics of North America, 53(3), 493–507. https://doi.org/10.1016/j.gtc.2023.12.007
Publication Date
Householder, S., Ramakrishnan, A., Chen, J. K., Gorsch, L., Tsapepas, D., Lobritto, S., Rundle, A., & Vittorio, J. M. (2024). The use of once‐daily LCP‐Tacrolimus with adolescent and young adult solid organ transplant recipients. Pediatric Transplantation, 28(4). Portico. https://doi.org/10.1111/petr.14777
Publication Date
Askanase, A. D., Furie, R. A., Dall’Era, M., Bomback, A. S., Schwarting, A., Zhao, M.-H., Bruce, I. N., Khamashta, M., Rubin, B., Carroll, A., Daniels, M., Levy, R. A., van Vollenhoven, R., & Urowitz, M. B. (2024). Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus Science & Medicine, 11(1), e001124. https://doi.org/10.1136/lupus-2023-001124
Publication Date
Lange, N. W., King, K., Husain, S. A., Salerno, D. M., Tsapepas, D. S., Hedvat, J., Yu, M., & Mohan, S. (2024). Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials. American Journal of Transplantation, 24(6), 1027–1034. https://doi.org/10.1016/j.ajt.2024.02.015
Publication Date
Jennings, D. L., & Baker, W. L. (2023). Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(2), 115–121. Portico. https://doi.org/10.1002/phar.2757
Publication Date
Columbia Affiliation
Thaniyavarn, T., Grewal, H. S., Goldberg, H. J., & Arcasoy, S. M. (2022). Nonallograft Complications of Lung Transplantation. Thoracic Surgery Clinics, 32(2), 243–258. https://doi.org/10.1016/j.thorsurg.2022.01.004
Publication Date
Cremers, S., Lyashchenko, A., Rai, A. J., Hayden, J., Dasgupta, A., Tsapepas, D., & Mohan, S. (2022). Challenged comparison of tacrolimus assays. Scandinavian Journal of Clinical and Laboratory Investigation, 82(3), 246–250. https://doi.org/10.1080/00365513.2022.2056858
Publication Date